Clinical Trial Update: Mannitol Dose Response Study in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial of inhaled mannitol for cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Mannitol (mannitol)

Snippet

Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED